Nguyen LS, Cooper LT, Kerneis M, Funck-Brentano C, Silvain J, Brechot N, Hekimian G, Ammirati E, Ben M’Barek B, Redheuil A, et al. Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database. Nat Commun. 2022;13:25. https://doi.org/10.1038/s41467-021-27631-8.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

• Ammirati E, Cavalotti C, Milazzo A, Pedrotti P, Soriano F, Schroeder JW, Morici N, Giannattasio C, Frigerio M, Metra M, et al. Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection. Int J Cardiol Heart Vasc. 2021;34. https://doi.org/10.1016/j.ijcha.2021.100774. First description of mRNA COVID-19 vaccine-associated acute myocarditis.

Larson KF, Ammirati E, Adler ED, Cooper LT Jr, Hong KN, Saponara G, Couri D, Cereda A, Procopio A, Cavalotti C, et al. Myocarditis after BNT162b2 and mRNA-1273 vaccination. Circulation. 2021;144:506–8. https://doi.org/10.1161/circulationaha.121.055913.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marshall M, Ferguson ID, Lewis P, Jaggi P, Gagliardo C, Collins JS, Shaughnessy R, Caron R, Fuss C, Corbin KJE, et al. Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics. 2021;148. https://doi.org/10.1542/peds.2021-052478.

•• Block JP, Boehmer TK, Forrest CB, Carton TW, Lee GM, Ajani UA, Christakis DA, Cowell LG, Draper C, Ghildayal N, et al. Cardiac complications after SARS-CoV-2 infection and mRNA COVID-19 vaccination - PCORnet, United States, January 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71:517–523. https://doi.org/10.15585/mmwr.mm7114e1. Large data from the CDC on estimation of myocarditis and pericarditis after mRNA COVID-19 vacciantion.

Pillay J, Gaudet L, Wingert A, Bialy L, Mackie AS, Paterson DI, Hartling L. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review. BMJ. 2022;378: e069445. https://doi.org/10.1136/bmj-2021-069445.

Article  PubMed  Google Scholar 

Witberg G, Barda N, Hoss S, Richter I, Wiessman M, Aviv Y, Grinberg T, Auster O, Dagan N, Balicer RD, et al. Myocarditis after Covid-19 vaccination in a large health care organization. N Engl J Med. 2021;385:2132–9. https://doi.org/10.1056/NEJMoa2110737.

Article  CAS  PubMed  Google Scholar 

• Cho JY, Kim KH, Lee N, Cho SH, Kim SY, Kim EK, Park JH, Choi EY, Choi JO, Park H, et al. COVID-19 vaccination-related myocarditis: a Korean nationwide study. Eur Heart J. 2023;44:2234–43. https://doi.org/10.1093/eurheartj/ehad339. Mortality rate is higher compared with other series. Interesting description of 36 cases of fulminant myocarditis.

Patone M, Mei XW, Handunnetthi L, Dixon S, Zaccardi F, Shankar-Hari M, Watkinson P, Khunti K, Harnden A, Coupland CAC, et al. Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex. Circulation. 2022;146:743–54. https://doi.org/10.1161/circulationaha.122.059970.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Conte E, Leoni O, Ammirati E, Imazio M, Brucato A. Incidence of myocarditis and pericarditis considered as separate clinical events over the years and post-SARS-CoV2 vaccination in adults and children. Eur J Intern Med. 2023. https://doi.org/10.1016/j.ejim.2023.06.002.

Article  PubMed  PubMed Central  Google Scholar 

Massari M, Spila Alegiani S, Morciano C, Spuri M, Marchione P, Felicetti P, Belleudi V, Poggi FR, Lazzeretti M, Ercolanoni M, et al. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: a multi-database, self-controlled case series study. PLoS Med. 2022;19: e1004056. https://doi.org/10.1371/journal.pmed.1004056.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naveed Z, Li J, Wilton J, Spencer M, Naus M, Velásquez García HA, Kwong JC, Rose C, Otterstatter M, Janjua NZ. Comparative risk of myocarditis/pericarditis following second doses of BNT162b2 and mRNA-1273 coronavirus vaccines. J Am Coll Cardiol. 2022;80:1900–8. https://doi.org/10.1016/j.jacc.2022.08.799.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karlstad Ø, Hovi P, Husby A, Härkänen T, Selmer RM, Pihlström N, Hansen JV, Nohynek H, Gunnes N, Sundström A, et al. SARS-CoV-2 vaccination and myocarditis in a Nordic cohort study of 23 million residents. JAMA Cardiol. 2022;7:600–12. https://doi.org/10.1001/jamacardio.2022.0583.

Article  PubMed  PubMed Central  Google Scholar 

•• Ammirati E, Moslehi JJ. Diagnosis and treatment of acute myocarditis: a review. JAMA. 2023;329:1098–113. https://doi.org/10.1001/jama.2023.3371. Recent update on acute myocarditis with suggested therapies for different etiologies.

Cui G, Li R, Zhao C, Wang DW. Case report: COVID-19 vaccination associated fulminant myocarditis. Front Cardiovasc Med. 2021;8: 769616. https://doi.org/10.3389/fcvm.2021.769616.

Article  PubMed  Google Scholar 

Dong YM, Liu X, Yang CT, Qi Q, Shi WB, Li YM, Zuo M, Wang SJ, Bi HT, Ma RF, et al. Case report: myocarditis following COVID-19 protein subunit vaccination. Front Cardiovasc Med. 2022;9: 970045. https://doi.org/10.3389/fcvm.2022.970045.

Article  PubMed  PubMed Central  Google Scholar 

Ammirati E, Lupi L, Palazzini M, Hendren NS, Grodin JL, Cannistraci CV, Schmidt M, Hekimian G, Peretto G, Bochaton T, et al. Prevalence, characteristics, and outcomes of COVID-19-associated acute myocarditis. Circulation. 2022;145:1123–39. https://doi.org/10.1161/circulationaha.121.056817.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021;144:471–84. https://doi.org/10.1161/circulationaha.121.056135. The first review article on myocarditis following COVID-19 mRNA vaccine.

Oster ME, Shay DK, Su JR, Gee J, Creech CB, Broder KR, Edwards K, Soslow JH, Dendy JM, Schlaudecker E, et al. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA. 2022;327:331–40. https://doi.org/10.1001/jama.2021.24110.

Article  CAS  PubMed  PubMed Central  Google Scholar 

• Ammirati E, Lupi L, Palazzini M, Ciabatti M, Rossi VA, Gentile P, Uribarri A, Vecchio CR, Nassiacos D, Cereda A, et al. Outcome and morphofunctional changes on cardiac magnetic resonance in patients with acute myocarditis following mRNA COVID-19 vaccination. Circ Heart Fail. 2023;16:e010315. https://doi.org/10.1161/CIRCHEARTFAILURE.122.010315. Recent data on functional and morphological changes on CMRI after mRNA COVID-19 vaccine-associated myocarditis.

Jain SS, Steele JM, Fonseca B, Huang S, Shah S, Maskatia SA, Buddhe S, Misra N, Ramachandran P, Gaur L, et al. COVID-19 Vaccination-associated myocarditis in adolescents. Pediatrics. 2021;148. https://doi.org/10.1542/peds.2021-053427.

Truong DT, Dionne A, Muniz JC, McHugh KE, Portman MA, Lambert LM, Thacker D, Elias MD, Li JS, Toro-Salazar OH, et al. Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: suspected myocarditis after COVID-19 vaccination. Circulation. 2022;145:345–56. https://doi.org/10.1161/circulationaha.121.056583.

Article  CAS  PubMed  Google Scholar 

Samimisedeh P, Jafari Afshar E, Shafiabadi Hassani N, Rastad H. Cardiac MRI Findings in COVID-19 vaccine-related myocarditis: a pooled analysis of 468 patients. J Magn Reson Imaging. 2022. https://doi.org/10.1002/jmri.28268.

Article  PubMed  PubMed Central  Google Scholar 

Fronza M, Thavendiranathan P, Chan V, Karur GR, Udell JA, Wald RM, Hong R, Hanneman K. Myocardial injury pattern at MRI in COVID-19 vaccine-associated myocarditis. Radiology. 2022;304:553–62. https://doi.org/10.1148/radiol.212559.

Article  PubMed  Google Scholar 

Aquaro GD, Perfetti M, Camastra G, Monti L, Dellegrottaglie S, Moro C, Pepe A, Todiere G, Lanzillo C, Scatteia A, et al. Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function: ITAMY study. J Am Coll Cardiol. 2017;70:1977–87. https://doi.org/10.1016/j.jacc.2017.08.044.

Article  PubMed  Google Scholar 

Ammirati E, Cipriani M, Moro C, Raineri C, Pini D, Sormani P, Mantovani R, Varrenti M, Pedrotti P, Conca C, et al. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: Multicenter Lombardy Registry. Circulation. 2018;138:1088–99. https://doi.org/10.1161/CIRCULATIONAHA.118.035319.

Article  PubMed  Google Scholar 

Lai FTT, Chan EWW, Huang L, Cheung CL, Chui CSL, Li X, Wan EYF, Wong CKH, Chan EWY, Yiu KH, et al. Prognosis of myocarditis developing after mRNA COVID-19 vaccination compared with viral myocarditis. J Am Coll Cardiol. 2022;80:2255–65. https://doi.org/10.1016/j.jacc.2022.09.049.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kracalik I, Oster ME, Broder KR, Cortese MM, Glover M, Shields K, Creech CB, Romanson B, Novosad S, Soslow J, et al. Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study. Lancet Child Adolesc Health. 2022;6:788–98. https://doi.org/10.1016/s2352-4642(22)00244-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, Friedrich MG, Klingel K, Lehtonen J, Moslehi JJ, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail. 2020;13: e007405. https://doi.org/10.1161/circheartfailure.120.007405.

Article  PubMed  PubMed Central  Google Scholar 

• Abbate A, Gavin J, Madanchi N, Kim C, Shah PR, Klein K, Boatman J, Roberts C, Patel S, Danielides S. Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. Int J Cardiol. 2021;340:119–21. https://doi.org/10.1016/j.ijcard.2021.08.018. First description of mRNA COVID-19 vaccine-associated fulminant myocarditis.

Ammirati E, Veronese G, Cipriani M, Moroni F, Garascia A, Brambatti M, Adler ED, Frigerio M. Acute and fulminant myocarditis: a pragmatic clinical approach to diagnosis and treatment. Curr Cardiol Rep. 2018;20:114. https://doi.org/10.1007/s11886-018-1054-z.

Article  PubMed  Google Scholar 

Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA, Shah RV, Sims DB, Thiene G, Vardeny O. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation. 2020;141:e69–92. https://doi.org/10.1161/cir.0000000000000745.

Article  PubMed  Google Scholar 

Ammirati E, Veronese G, Brambatti M, Merlo M, Cipriani M, Potena L, Sormani P, Aoki T, Sugimura K, Sawamura A, et al. Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2019;74:299–311. https://doi.org/10.1016/j.jacc.2019.04.063.

Article  PubMed  Google Scholar 

Kondo T, Okumura T, Shibata N, Imaizumi T, Dohi K, Izawa H, Ohte N, Amano T, Murohara T. Differences in prognosis and cardiac function according to required percutaneous mechanical circulatory support and histological findings in patients with fulminant myocarditis: insights from the CHANGE PUMP 2 study. J Am Heart Assoc. 2022;11: e023719. https://doi.org/10.1161/jaha.121.023719.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanaoka K, Onoue K, Terasaki S, Nakano T, Nakai M, Sumita Y, Hatakeyama K, Terasaki F, Kawakami R, Iwanaga Y, et al. Features and outcomes of histologically proven myocarditis with fulminant presentation. Circulation. 2022;146:1425–33. https://doi.org/10.1161/circulationaha.121.058869.

Article  PubMed  Google Scholar 

Huang F, Ammirati E, Ponnaiah M, Montero S, Raimbault V, Abrams D, Lebreton G, Pellegrino V, Ihle J, Bottiroli M, et al. Fulminant myocarditis proven by early biopsy and outcomes. Eur Heart J. 2023;44:5110–24. https://doi.org/10.1093/eurheartj/ehad707.